“valeant-pharmaceuticals” Archives

in
Entry Author Date Location
Bio Roundup: A Telehealth Combo, FDA’s BCMA OK, Biogen’s Bet & More 08/07/20 National
Rapamycin Holdings Changes Name to Emtora Biosciences, Hires New CEO 02/26/19 Texas
Bio Roundup: Duchenne Data, Roche Buys Foundation, IPO Wave & More 06/22/18 National
Bio Roundup: Lung Cancer Showdown, Gene Therapy Deals, IPO Busts 04/13/18 National
Two Months Ahead of Schedule, FDA Clears Aerie Glaucoma Drug 12/19/17 New York
Bio Roundup: Barron Joins GSK, Sage Bounces Back, Valeant Dumps Addyi 11/10/17 National
$1B For Nothing? Valeant Sells Sex Drug to Sprout Backers for a Pittance 11/06/17 Raleigh Durham
Report: Martin Shkreli Faces Prison Term After Fraud Conviction 08/04/17 New York
Ex-Dendreon CEO, Gold, Returns to Wall Street as Alpine, Nivalis Merge 04/18/17 Seattle
War, Surgery, and Cancer Vaccines: Meet San Antonio’s George Peoples 08/19/16 Texas
Allergan Pays $95M for ForSight VISION5, Eye Insert for Glaucoma 08/11/16 San Francisco
Biotech Roundup: Scangos’s Exit, Zafgen’s Shakeup, Jounce, Relypsa & More 07/22/16 National
Arrivo BioVentures Lands $49M to Fuel Hunt for New Drugs 05/26/16 Raleigh Durham
Four Years After Neuronex Buyout, Acorda Dumps Epilepsy Drug 05/20/16 New York
NC Biotech, Windsor Circle, Willow Hill, & More NC Innovation News 05/02/16 Raleigh Durham
Envisia Gets $16.5M More to Back Extended-Release Eye Drugs 03/23/16 Raleigh Durham
North Carolina Equity Investments Double, Topping $1B in 2015 02/18/16 Raleigh Durham
East Coast Bio Roundup: CRISPR, Tessier-Lavigne, Pricing, Spero & More 02/05/16 Boston
Patheon’s Mullen: Drug Price Debate Could Shape Pharma’s Future 10/27/15 Raleigh Durham
Biopharma CEOs, VCs, and Hedge Fund Managers: Fifty Shades of Greed 10/07/15 National
Amid Biotech Swoon, Third Rock’s MyoKardia Tees up IPO 09/28/15 San Francisco
East Coast Biotech Roundup: WaVe, Shkreli, Intarcia & More 08/21/15 Boston
Drug Discovery in Seattle 2015: An Updated History 08/03/15 Seattle
East Coast Biotech Roundup: Biogen, Epizyme, Armored CARS, & More 07/13/15 Boston
XRpro Resurrects Icagen With Buy of Some Pfizer Ion Channel Assets 07/02/15 Boston
BioDelivery Sciences Lands $20M to Prep for Drug Launch 06/01/15 Raleigh Durham
Irritable Bowel Drugs Originally Developed by NC Firms Win FDA Nod 05/27/15 Raleigh Durham
Raleigh-Durham Roundup: Quintiles, BDSI, BioCryst, & More 04/06/15 Raleigh Durham
Academia vs. BioPharma: Young Scientists Between A Rock and A Hard Place 04/06/15 Seattle
Valeant Boosts Bid For Salix By $1B, Endo Withdraws 03/16/15 Raleigh Durham
Page 1 of 2 next page »